Békés Megyei Központi Kórház

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Ruben A. Mesa, Alessandro M. Vannucchi, Adam J. Mead et al. · The Lancet Haematology · 2017 · 300 citations · Full text

Hematological Malignancy, Oncology, Pacritinib Versus +9

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

Arvind Dasari, Sara Lonardi, Rocio García‐Carbonero et al. · The Lancet · 2023 · 279 citations · Full text

Oncology, Gastrointestinal Oncology, Colorectal Cancer +6

Prospective, Multicentre, Nationwide Clinical Data from 600 Cases of Acute Pancreatitis

Andrea Párniczky, Balázs Kui, Andrea Szentesi et al. · PLoS ONE · 2016 · 252 citations · Full text

Long-term intra-individual variability of the background EEG in normals

András Kondacs, Mihály Szabó · Clinical Neurophysiology · 1999 · 212 citations

Background Eeg, Eeg Signal Processing, Neuroimaging +6

Effect of Pioglitazone Compared with Metformin on Glycemic Control and Indicators of Insulin Sensitivity in Recently Diagnosed Patients with Type 2 Diabetes

Imre Pávó, György Jermendy, Tamás Várkonyi et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 164 citations · Full text

Metabolic Syndrome, Insulin Sensitivity, Diabetes Management +13